{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:17:27Z","timestamp":1777407447555,"version":"3.51.4"},"reference-count":48,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Xenobiotica"],"published-print":{"date-parts":[[2025,2,7]]},"DOI":"10.1080\/00498254.2025.2475501","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T23:22:51Z","timestamp":1742253771000},"page":"99-109","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Inhibition of ABC transporters by sorafenib and lenvatinib: implications for drug-induced cholestasis"],"prefix":"10.1080","volume":"55","author":[{"given":"Getahun Befirdu","family":"Abza","sequence":"first","affiliation":[{"name":"Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven","place":["Leuven, Belgium"]},{"name":"Department of Pharmacology, School of Pharmacy, Jimma University","place":["Jimma, Ethiopia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristof","family":"De Vos","sequence":"additional","affiliation":[{"name":"Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven","place":["Leuven, Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Annaert","sequence":"additional","affiliation":[{"name":"Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven","place":["Leuven, Belgium"]},{"name":"BioNotus","place":["Niel, Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.175034"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.117.077289"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12458"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24682"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp4001348"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26187"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1124\/DMD.111.040758"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.773973"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJPS.2022.106362"},{"key":"e_1_3_4_11_1","unstructured":"DrugBank. No Title. https:\/\/go.drugbank.com\/."},{"key":"e_1_3_4_12_1","unstructured":"EMA 2015. Guideline on the investigation of drug interactions\u2014Revision 1 (CPMP\/EWP\/560\/95\/Rev.1 Corr.2**). [accessed 2024 May 23]. https:\/\/www.ema.europa.eu\/en\/investigation-drug-interactions-scientific-guideline#current-effective-version-under-revision-section."},{"key":"e_1_3_4_13_1","unstructured":"EMA 2016. Assessment report. Lenvima. International non-proprietary name: lenvatinib. Procedure No. EMEA\/H\/C\/003727\/0000. Committee for Medicinal Products for Human Use (CHMP). EMA\/250082\/2015. 30. London 26 March 2015 44(March 2015)."},{"key":"e_1_3_4_14_1","unstructured":"FDA 2024. M12 Drug Interaction Studies Guidance for Industry ICH-Multidisciplinary. (August). https:\/\/www.fda.gov\/vaccines-blood-biologics\/guidance-compliance-regulatory-information-biologics\/biologics-guidances."},{"key":"e_1_3_4_15_1","first-page":"1","article-title":"Center for Drug Evaluation and Clinical Pharmacology and Biopharmaceutics Review","author":"FDA","year":"2009","unstructured":"FDA. 2009. Center for Drug Evaluation and Clinical Pharmacology and Biopharmaceutics Review. Food Drug Administration; 1\u20135. Reference ID: 3687049. New Drug Application.","journal-title":"Food Drug Administration"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.120.000086"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-109"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJPS.2013.04.032"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0048"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03963.x"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.028886"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1222"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.024778"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.054304"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2017.1393582"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-09-0663"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(24)38310-7"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfw209"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfq269"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.114.059832"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-019-41820-Y"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.03.017"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/01926233231212255"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1124\/JPET.121.000828"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.7b00563"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.5097-20"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.048181"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/CPT.1693"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010029"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2017.04.053"},{"issue":"1","key":"e_1_3_4_41_1","first-page":"1","article-title":"In vitro drug interaction studies \u2013 cytochrome P450 enzyme and transporter mediated drug interactions","volume":"1","author":"US FDA","year":"2020","unstructured":"US FDA. 2020. In vitro drug interaction studies \u2013 cytochrome P450 enzyme and transporter mediated drug interactions. FDA Guid. 1(1):1\u201346. https:\/\/www.fda.gov\/media\/134582\/download.","journal-title":"FDA Guid"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-9420-5_4"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-0280"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2003.10.008"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23089"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498254.2015.1109160"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3306"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-1967"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01033.x"}],"container-title":["Xenobiotica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00498254.2025.2475501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T06:38:16Z","timestamp":1749537496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00498254.2025.2475501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,7]]}},"alternative-id":["10.1080\/00498254.2025.2475501"],"URL":"https:\/\/doi.org\/10.1080\/00498254.2025.2475501","relation":{},"ISSN":["0049-8254","1366-5928"],"issn-type":[{"value":"0049-8254","type":"print"},{"value":"1366-5928","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ixen20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ixen20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-12-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}